To Evaluate the Effect of AZD3199 on the Electrical Activity in the Heart
Status:
Completed
Trial end date:
2011-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to evaluate the effect of AZD3199 on the electrical
activity of the heart. The effect of AZD3199 will be compared to a licensed antibiotic
(moxifloxacin). Moxifloxacin effects on the electrical activity of the heart are well known.
Safety and tolerability of AZD3199 and how much AZD3199 enters the blood circulation will
also be assessed.
Phase:
Phase 1
Details
Lead Sponsor:
AstraZeneca
Treatments:
AZD-3199 Fluoroquinolones Moxifloxacin Norgestimate, ethinyl estradiol drug combination